KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Financing Activities (2016 - 2026)

Biogen has reported Cash from Financing Activities over the past 18 years, most recently at -$43.8 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 90.43% year-over-year to -$43.8 million; the TTM value through Mar 2026 reached -$322.7 million, down 20.91%, while the annual FY2025 figure was -$301.9 million, 55.83% up from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$43.8 million at Biogen, up from -$137.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $848.6 million in Q3 2023 and troughed at -$1.3 billion in Q3 2022.
  • A 5-year average of -$154.5 million and a median of -$43.4 million in 2023 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 167.78% in 2023 and fell as far as 8631.08% in 2023.
  • Year by year, Cash from Financing Activities stood at -$7.4 million in 2022, then tumbled by 8631.08% to -$646.1 million in 2023, then surged by 101.22% to $7.9 million in 2024, then crashed by 1834.18% to -$137.0 million in 2025, then soared by 68.03% to -$43.8 million in 2026.
  • Business Quant data shows Cash from Financing Activities for BIIB at -$43.8 million in Q1 2026, -$137.0 million in Q4 2025, and -$130.2 million in Q3 2025.